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We report the unprecedented complete absence of pediatric 
enteroviral meningitis in 2020 in the area of Bern, Switzerland. 
Presumably an unintended effect of coronavirus disease 2019 
public health measures, this finding highlights the potential of 
community-wide nonpharmaceutical interventions for con-
trolling the circulation of a major pediatric pathogen, which is 
mainly transmitted by the fecal–oral route.
Keywords.  child; COVID-19; Enterovirus; epidemiology; 
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In temperate climates, infections caused by nonpoliovirus en-
teroviruses (EVs) in children peak between June and October 
[1–3]. Outbreaks recur each year despite cycling changes of the 
predominant EV types [1, 4]. Human-to-human transmission 
occurs primarily via the fecal–oral route, and less commonly 
by respiratory secretions [5]. EVs cause various nonspecific fe-
brile syndromes. They are also the most commonly identified 
etiology of acute central nervous system (CNS) infection in 
children [6], with the greatest age-specific incidence in infants 
[4, 6].
At our institution, EV meningitis case counts peak each 
summer, and testing cerebrospinal fluid (CSF) for EV by poly-
merase chain reaction (PCR) is part of the standard diagnostic 
algorithm for all infants <90  days of age undergoing lumbar 
puncture for sepsis workup and for children of any age evalu-
ated for possible meningitis.
Unexpectedly, we observed no case in 2020. Here we describe 
the occurrence of EV meningitis over 11 consecutive years 
and correlate the epidemic curve with the timing of various 
nonpharmaceutical interventions (NPIs) introduced to halt 
the coronavirus disease 2019 (COVID-19) pandemic in 2020. 
As the NPIs were primarily designed to interrupt respiratory 
transmissions and EVs may also, albeit less commonly, be trans-
mitted by the respiratory route, we also calculated the epidemic 
curve for respiratory rhinovirus/enterovirus detections.
METHODS
This is a retrospective single-center time series analysis of the 
occurrence of EV meningitis at an institution, which is the only 
provider of advanced pediatric emergency services (20  000 
consultations per year) and inpatient services (100 beds; 6000 
admissions per year) for a catchment area population of 1.5 mil-
lion. We defined EV meningitis as the detection of enteroviral 
RNA by CSF PCR, which was introduced in 2010/2011 to the 
in-house diagnostic algorithm for infants <90 days of age under-
going sepsis workup and pediatric patients of any age evaluated 
for meningitis. Using the electronic hospital database, we ana-
lyzed 3 separate data sets from January 1, 2010, to December 31, 
2020: (1) CSF real-time EV PCR test results were used to capture 
the number of patients tested and the number of EV meningitis 
cases; (2) hospital admissions coded for EV meningitis (ICD-
10 code A87.0) were obtained for validation of PCR results; (3) 
nasopharyngeal aspirate (NPA) immunofluorescence (IF) tests 
for rhinovirus/enterovirus [7] were obtained to monitor overall 
respiratory rhinovirus/enterovirus activity (IF assay does not 
distinguish between rhinoviruses and enteroviruses). For each 
case, the date and patient age were recorded. We plotted counts 
by month, quarter, or year and performed a time series analysis 
comparing the frequencies in 2020 with those in 2010–2019. 
We performed separate analyses for patients <1 year of age and 
patients 1 to 16 years of age.
We calculated the average epidemic curve from January 1, 2010, 
to December 31, 2019, using the method recommended by the 
World Health Organization Global Epidemiological Standards for 
Influenza (https://www.who.int/influenza/resources/documents/
influenza_surveillance_manual/en/). We used a generalized linear 
model with a Poisson distribution to predict expected numbers for 
2020 based on annual counts of EV CSF PCR tests, NPA IF tests, 
and ICD-10 code counts for the years 2010 to 2019. Statistical 
analysis was performed using the R software package, version 4.0.3 
(Vienna, Austria; https://www.R-project.org/). Start and end dates 
of NPIs implemented in Switzerland during the first wave of the 
COVID-19 pandemic were provided by the Swiss Federal Office 
of Public Health and are detailed in the Supplementary Table 1.
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RESULTS
During 11 consecutive years from 2010 to 2020, we observed 
178 and 110 cases of EV meningitis among children 0–1 and 
1–16 years of age. Both the annual frequencies and proportions 
of positive CSF EV PCR tests are shown in Figure 1. The counts 
of hospitalizations coded for EV meningitis (ICD-10 code 
A87.0) are also provided. The Supplementary Data provides the 
raw data for all patients (Table 2).
The predicted counts for 2020 for CSF EV PCR tests per-
formed and positive (ie, EV meningitis cases), respectively, 
based on the observed cases in infants from 2010 to 2019 
were 62 (95% CI, 47–78) and 20 (95% CI, 12–29), respec-
tively. However, only 21 patients were tested for EV, and 
none was positive (Figure 1 A). A similar discrepancy was 
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Figure 1. Timeline of Enterovirus meningitis in infants (A and B) and children 1–16 years of age (C and D) at the Bern University Hospital. A and C, Open circles indicate the 
annual number of EV CSF PCR tests performed, open squares indicate the annual number of positive EV detections in CSF, and open triangles indicate the annual number of 
patients in whom a discharge diagnosis of EV meningitis was coded. B and D, Detection rates of EV RNA in CSF in infants (B) and children 1–16 years of age (D). aPredicted 
annual numbers in 2020 of infants (A) and children 1–16 years of age (C) with EV CSF PCR tests performed (open circle) and positive (open square) based on a time series 
analysis (2010–2019). Vertical bars indicate the 95% CI. Abbreviations: CSF, cerebrospinal fluid; EV, Enterovirus; PCR, polymerase chain reaction.
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The seasonal distribution of cases shown in Figure 2 demon-
strates that from 2010 to 2019 most cases clustered in the third 
quarter (115 of 178 cases [65%] were <1 year old; 66 of 110 cases 
[60%] were 1–16 years old). In 2020, no cases were diagnosed 
even though most NPIs had been lifted at that time. In partic-
ular, primary and secondary schools had been opened by May 
11, 2020, after 2 months of closure, and day care facilities had 
never been closed.
Analysis of the time trends for rhinovirus/enterovirus de-
tections by IF in NPA revealed that detections occurred 
throughout the year and peaked either in the second or fourth 
quarter, but never in the third quarter (data not shown). While 
both the number of tests performed and positive detections in 
2020 were significantly lower than predicted (Supplementary 
Table 3), the reduction was only ~50% compared with 100% for 
EV CSF PCR.
DISCUSSION
NPIs to prevent the spread of COVID-19 have been associ-
ated with markedly decreased community activity of major 
respiratory viruses other than severe acute respiratory disease 
coronavirus 2 (SARS-CoV-2) [8–11]. Here we report the com-
plete absence in 2020 of the summer outbreak of enteroviral 
meningitis, which previously peaked in the third quarter of 
each year since at least 2010. This finding strongly suggests 
that community-wide COVID-19 control measures intended 
to prevent respiratory transmissions also dramatically impacted 
enteroviral transmission, which most commonly occurs by di-
rect human-to-human contact [5].
This striking disruption of enteroviral epidemic cycles was 
first reported for the second quarter of 2020 from Korea [9] 
and Taiwan [12–14] by analysis of a national health insur-
ance database [12], ICD codes for hand, foot, and mouth dis-
ease and herpangina [13], and national disease notification 
systems [9, 14]. More recently, 2 clinical microbiology reports 
from Southeast France [15] and the United States [16] describe 
the near absence in EV CSF PCR detections during the third 
quarter of 2020.
The starting point of our study was the clinical observation of 
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Figure 2. Average epidemic curve of EV meningitis at the Bern University Hospital. Black dots indicate the mean number of EV meningitis cases in infants, and open 
triangles indicate the average number of EV meningitis cases in children 1–16 years of age based on data from 2010 to 2019. Red dots indicate the number of children 
0–16 years of age with CSF EV RNA detection in 2020. NPIs in 2020 are indicated by numbers: ① hygiene recommendations in educational setting, 02/27/2020–ongoing; 
②social distancing >1.5 m, 03/06/2020–ongoing; ③ gatherings >100 persons banned, 03/13/2020–06/06/2020; ④ public venues closed, 03/06/2020–05/11/2020; ⑤ 
tertiary schools and universities closed (age >16 years), 03/16/2020–06/06/2020; ⑥ primary and secondary schools closed (age 6–12 years), 03/16/2020–05/11/2020; ⑦ 
gatherings >5 persons banned, 03/20/2020–06/06/2020; ⑧face masks in public transport (age >12 years), 07/05/2020–ongoing; ⑨ face masks (outdoors and public indoor 
venues, age >12 years), 10/19/2020–ongoing; ⑩ private gatherings >15 persons banned, 10/29/2020–ongoing. Abbreviations: CSF, cerebrospinal fluid; EV, enterovirus; NPI, 
nonpharmaceutical intervention.
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to be a suitable sentinel population for enteroviral circulation 
in the community, because their febrile presentation is usually 
brought to medical attention and the workup for fever without 
source or meningitis commonly includes EV PCR in CSF and/
or blood [17]. Conversely, for older children such data may be 
less reliable, because EV disease is mostly mild, nonspecific, 
and rarely confirmed virologically. Also, health care avoidance 
during lockdown periods [18, 19] may have negatively affected 
the case counts for such minor and self-limited illnesses. Thus, 
our clinical observation on infant EV meningitis corroborates 
what public health authorities and clinical microbiologists have 
recently reported.
Correlating the epidemic curve with various NPIs (Figure 
2) reveals several important insights. Hand hygiene and so-
cial distancing recommendations were the only NPIs in place 
in Switzerland throughout the entire observation period and 
appear to be the most likely drivers of reduced enteroviral 
circulation. Day care centers were never closed [11]. While 
horizontal spread of EV in this setting is well established 
[20], our findings suggest that effective control of com-
munity transmission is possible without day care closure. 
Similarly, schools were reopened well before the expected 
onset of the EV season [11]. Thus, school closure between 
March and May 2020 was either irrelevant for subsequent 
EV suppression in the third quarter or exerted a critical 
delay by reducing early reproduction in spring. Finally, the 
use of face masks in public was not enforced until later in 
the year and, consistent with primarily fecal–oral transmis-
sion, is unlikely to have contributed substantially. The reduc-
tion of combined rhinovirus/enterovirus detection in NPA 
in 2020 was significant, but substantially less pronounced 
(Supplementary Table 3) than EV detection in CSF. This sug-
gests that there was ongoing circulation of respiratory types 
of the genus Enterovirus, that is, mainly rhinoviruses [21], 
while nonrespiratory enterovirus genotypes, which cause the 
majority of CNS infections, were largely suppressed. This 
further supports the notion that fecal–oral transmission was 
disrupted in 2020.
The strengths of this study include the long observation 
period and the hospital setting, which affords greater preci-
sion in associating EV detection with specific clinical disease 
than public health or clinical microbiology data. Limitations 
include the following: First, our single-site approach may not 
be representative of other geographic areas. Second, we did 
not routinely search for parechoviral infections in CSF, which 
in Europe occur with biannual peaks in even-numbered years 
[3]. However, EV and parechoviruses co-circulate with no 
apparent mutual interference [2]. Third, we may have under-
estimated the true number of EV meningitis cases as CSF 
PCR is less sensitive for detection of EV than PCR of stool or 
respiratory specimens [22]. Fourth, as with all retrospective 
studies, factors unaccounted for may have contributed to the 
effects observed.
CONCLUSIONS
Evidence from 3 continents demonstrates that enteroviral 
summer activity was nearly abolished during the COVID-
19 pandemic year. This unintended effect of NPI to control 
COVID-19 presumably had a major protective effect against 
the burden of pediatric EV CNS summer disease and the uti-
lization of health care resources. Further studies are needed to 
dissect the specific set of NPIs responsible for this collateral ef-
fect. This could be beneficial for postpandemic pediatric dis-
ease prevention.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility 
of the authors, so questions or comments should be addressed to the 
corresponding author.
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